Sleepless nights ahead for Cann Group as over-the-counter CBD trial fails the placebo challenge by Steve Jones January 19, 2023January 19, 2023 Cann Group’s plans to register an over-the-counter CBD medicine have been dealt a blow after a […]
Cann Group poised to scale-up production after securing A$8.2m from shareholders by Steve Jones December 5, 2022April 29, 2024
Bod strikes CBD over-the-counter deal with pharma firm Arrotex by Steve Jones December 2, 2022April 29, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Wellnex warns of ‘limited shelf space’ as firm lays groundwork for OTC launch by Steve Jones October 6, 2022April 29, 2024
Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022April 29, 2024
Ecofibre launches low-cost CBD product and pins hope on OTC market to drive profitability by Steve Jones August 23, 2022April 29, 2024
Over-the-counter sales to create ‘most significant opportunity in years’ says Ecofibre boss by Steve Jones August 3, 2022April 29, 2024
Bod’s S3 registration candidate to go on sale through Special Access Scheme by Steve Jones June 27, 2022April 29, 2024
